In-hospital use of ACEI/ARB is associated with lower risk of mortality and critic illness in COVID-19 patients with hypertension
- PMID: 32800800
- PMCID: PMC7422860
- DOI: 10.1016/j.jinf.2020.08.014
In-hospital use of ACEI/ARB is associated with lower risk of mortality and critic illness in COVID-19 patients with hypertension
Conflict of interest statement
Declaration of Competing Interest The authors declare no conflicts of interest.
Comment on
-
Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis.J Infect. 2020 Jul;81(1):e84-e86. doi: 10.1016/j.jinf.2020.03.059. Epub 2020 Apr 11. J Infect. 2020. PMID: 32283158 Free PMC article. No abstract available.
References
-
- Ferrario C., Jessup J., Chappell M., Averill D., Brosnihan K., Tallant E. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111:2605–2610. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
